Home / Contract Awards / Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

LeidosLogoLeidos (NYSE: LDOS) has been awarded a potential five-year, $23.7 million contract to support the U.S. Agency for International Development‘s efforts to research and develop a vaccine against malaria.

The company said Monday it will provide scientific and management services for USAID’s Malaria Vaccine Development Program under the cost-plus-fixed-fee contract.

Jerry Hogge, Leidos health deputy group president, said the company brings decades of life sciences technology and experience to the USAID program.

Leidos said the work to occur in Frederick, Maryland, could also evaluate malaria vaccine candidates during preclinical studies and clinical and field trials.

The company’s life sciences team supports medical product R&D efforts at the National Institutes of Health and the departments of Defense and Homeland Security.

Check Also

Yosry Barsoum, Gregg Leone, Scott Kordella Take New Mitre Public Sector Leadership Roles

Mitre has announced a series of leadership changes within the McLean, Virginia-based nonprofit company’s public …

BAE, ManTech Vet Dave Wallen to Join KeyW as Advanced Cyber SVP

Dave Wallen, senior vice president of ManTech International‘s (Nasdaq: MANT) cyber operations and exploitation business, …

Subscribe to our Newsletter
I will subscribe later